Crossbow Therapeutics, Inc

Crossbow Therapeutics, Inc. is dedicated to improving the lives of individuals affected by cancer through groundbreaking biotechnology research. Crossbow Therapeutics focuses on unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company's innovative T-Bolt™ therapies represent a new generation of precisely targeted immunotherapies designed for efficient assembly and unparalleled accuracy in reaching previously inaccessible cancer cell targets.

Crossbow Therapeutics' selective methodology aims to comprehensively address the entire spectrum of cancer proteins, significantly broadening the scope of antibody therapy to encompass diverse cancer types. Crossbow Therapeutics, Inc. is located at its primary address at 1030 Massachusetts Avenue, Suite 210, Cambridge, MA 02138, US.

Crossbow Therapeutics is committed to advancing the field of cancer treatment through cutting-edge research and development. The company continually strives to expand the possibilities of antibody therapy and provide hope for those battling cancer. We invite the management team at Crossbow Therapeutics, Inc. to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative work.